Screening for significant coronary artery disease in high-risk renal transplant candidates.

BACKGROUND: Renal transplant candidates are at an increased risk for coronary artery disease (CAD), a strong predictor of cardiovascular events [major adverse coronary events (MACE)]. Coronary angiography is a costly, risky, invasive procedure. We sought to determine clinical predictors of significant CAD (stenosis > or =70%) in high-risk renal transplant candidates. METHODS: Clinical evaluation and coronary angiography were performed in 301 patients (57+/-8 years, 73% men) on hemodialysis for 32 months (median). Patients were followed-up for 22 months (median). Inclusion criteria were diabetes (type 1 or 2), evidence of cardiovascular disease, or age > or =50 years. Risk factors included hypertension (93.7%), overweight/obesity (54.3%), dyslipidemia (44.9%), diabetes (42.1%), and smoking (24.3%). Cardiovascular disease was found as follows: peripheral arterial disease (PAD) (31.2%), angina (28.1%), stroke (12.9%), myocardial infarction (MI) (10.3%), and heart failure (9.3%). RESULTS: Significant CAD was found in 136 individuals (45.2%). Diabetes [odds ratio (OR)=1.82; 95% confidence interval (CI)=1.08-3.07], PAD (OR=2.50; 95% CI=1.44-4.37), and previous MI (OR=7.75; 95% CI=3.03-23.98) were associated with significant CAD. The prevalence of significant CAD increased with the number of clinical predictors from 26% (none) to 100% (all present) (P<0.0001). The incidence of fatal/nonfatal MACE increased two, four, and sixfold in those with diabetes, PAD, or previous MI, respectively (P<0.0001). CONCLUSIONS: In high-risk patients with end-stage renal disease, the prevalence of CAD and the incidence of MACE were high. Significant CAD or cardiovascular complications were not related to the majority of classic risk factors. Patients with diabetes, PAD, or previous MI are at higher risk of CAD, MACE, or both and, thus, must be referred for invasive diagnostic procedures.

[Intracoronary inflammatory markers after percutaneous coronary interventions]. / Marcadores inflamatórios intracoronarianos após intervenções coronarianas percutâneas.

OBJECTIVE: To analyze intracoronary release of inflammatory markers (IM) after percutaneous coronary interventions (PCI) and compare their concentrations concerning the type of PCI used (rotablator vs. balloon angioplasty). METHODS: Twenty-two patients with average age of 60 +/- 11.9 years old, 12 of male sex, with stable coronary disease, submitted to elective treatment of a single coronary lesion, using rotablator (N = 11) or balloon pre-dilatation (N = 11) for stent implant were randomized. Samples were collected at aorta root and coronary sinus, immediately before and 15 minutes after intervention. All dosages were made before stent implant, and the cytokines TNF-a, IL-6 and IL-1 and the soluble adhesion molecules ICAM-1, E-selectin and P-selectin were analyzed by using ELISA method. RESULTS: TNF-a and IL-6 concentrations increased after PCI, respectively from 9.5 +/- 1.5 pg/ml to 9.9 +/- 1.8 pg/ml (p = 0.017) and from 6.0 +/- 2.4 pg/ml to 6.9 +/- 3.0 pg/ml (p < 0.001). There was no significant changes in IL-1, ICAM-1 and P-selectin, and a decrease in E-selectin concentrations after the procedures (52.0 +/- 17.5 ng/ml to 49.3 +/- 18.7 ng/ml; p = 0.009) was observed. There were no significant differences between IM concentrations after PCI, concerning the type of procedure used. CONCLUSION: At the early period, post-percutaneous coronary interventions, an increase of intracoronary concentrations of TNF-a and IL-6, and absence of significant difference between concentrations of inflammatory markers released in coronary flow through rotablator and balloon angioplasty were observed.

[Comparative study between the therapeutic effects of surgical myocardial revascularization and coronary angioplasty in equivalent ischemic situations: analysis through myocardial scintigraphy with 99mTc-Sestamibi]. / Estudo comparativo entre os efeitos terapêuticos da revascularização cirúrgica do miocárdio e angioplastia coronária em situações isquêmicas equivalentes: análise através da cintilografia do miocárdio com 99mTc-Sestamibi.

OBJECTIVE: To assess the myocardial ischemic load to previous and after myocardial revascularization. METHODS: Ninety-six randomized patients, carriers of multivessel coronary artery disease, stable angina, preserved left ventricular function, and exercise-induced myocardial ischemia treated with revascularization (SMR) or coronary angioplasty (TCA). Myocardial scintigraphy with 99mTc-Sestamibi was performed prior to and 6 months after myocardial revascularization. RESULTS: The SMR determined a significant greater index of complete revascularization (p=0.001), an increase in the number of maximum ergometric tests (p=0.001) and reduction in the number of positive ergometric tests with exercise angina (p=0.018). Both procedures provided an important improvement in the functional class of angina (p=0.001), an increase in the average value of double peak product (p=0.009), and the time of exercise tolerance (p<0.001), besides the reduction in the average value of the summed of exercise score (p<0.001) and the difference of the summed of scores (p<0.001) in both groups. CONCLUSION: TCA and SMR did not differ significantly concerning the reduction of myocardial ischemic load 6 months after the procedure. The myocardial revascularization was more complete with the SMR than the TCA, but it did not represent a significant factor for the reduction myocardial ischemic load.

The importance of the interaction between leukocyte integrin Mac-1 and platelet glycoprotein Ib-a for leukocyte recruitment by platelets and for the inflammatory response to vascular injury.

OBJECTIVE: To assess the importance of the interaction between leukocyte integrin Mac-1 (a Mb 2) and platelet glycoprotein (GP) Ib-a for leukocyte recruitment after vascular injury and the effect of the neutralization of the Mac-1-GPIba interaction on cell proliferation and the neointimal hyperplasia triggered by the vascular injury. METHODS: A peptide called M2 or anti-M2 antibody was developed to block the Mac-1-GPIba interaction. This peptide was injected and compared to a control-peptide in C57B1/6J mice submitted to vascular injury of the femoral artery with a guide wire. One, five or 28 days after the vascular injury, the femoral arteries were removed for morphometric and immunohistochemical analyses. RESULTS: The blocking of the Mac-1-GPIba interaction promoted a statistically significant reduction in the number of leukocytes in the neointimal layer on the first day after the vascular injury (control: 7.9+/-5.0% of the cell total versus anti-M2: 2.0+/-1.6%, p=0.021), as well as determined a statistically significant decrease in leukocyte accumulation in the neointimal layer on days 5 and 28 (control: 42.3+/-12.9% versus anti-M2: 24.6+/-10.8%, p=0.047 and control: 7.9+/-3.0% versus anti-M2: 3.3+/-1.3%, p=0.012; respectively). Cell proliferation in the neointimal layer of the vessel five days post-injury was reduced with the blocking of the Mac-1-GPIba interaction (control: 5.0+/-2.9% of the cell total versus anti-M2: 1.8+/-0.5%; p=0.043), along with a significant decrease in cell proliferation in the vessel neointimal layer 28 days post-injury (control: 3.8+/-1.7% versus anti-M2: 2.0+/-1.2%; p=0.047). The blocking of the Mac-1-GPIba interaction also determined a statistically significant decrease of the intimal thickening 28 days post-injury (control: 10,395+/-3,549 microm(2) versus anti-M2: 4,561+/-4,915 microm(2); p=0.012). CONCLUSION: Leukocyte recruitment after a vascular injury depends on the Mac-1-GPIba interaction and the neutralization of this interaction inhibits cell proliferation and neointimal formation.

The importance of the interaction between leukocyte integrin Mac-1 and platelet glycoprotein Ib-a for leukocyte recruitment by platelets and for the inflammatory response to vascular injury / Importância da interação entre a integrina Mac-1 dos leucócitos e a glicoproteína Iba das plaquetas para o recrutamento de leucócitos pelas plaquetas e para a resposta inflamatória à lesão vascular

OBJETIVO: Avaliar a importância da interação entre a integrina Mac-1 dos leucócitos (a Mb 2) e a glicoproteína (GP) Iba das plaquetas para o recrutamento de leucócitos após a lesão vascular e o efeito da neutralização da interação Mac-1-GPIba sobre a proliferação celular e a hiperplasia neointimal desencadeadas por lesão vascular. MÉTODOS: Um peptídeo denominado M2 ou anticorpo anti-M2 foi desenvolvido para bloquear a interação Mac-1-GPIba . Esse peptídeo foi injetado e comparado com anticorpo-controle em camundongos C57B1/6J submetidos a lesão vascular da artéria femoral com corda-guia. Um, cinco ou 28 dias após a lesão vascular, as artérias femorais foram retiradas para a realização de morfometria e imuno-histoquímica. RESULTADOS: O bloqueio da interação Mac-1-GPIba promoveu uma redução estatisticamente significativa do número de leucócitos na camada média no primeiro dia após a lesão vascular (controle: 7,9±5,0 por cento do total de células versus anti-M2: 2,0±1,6 por cento, p=0,021), bem como determinou uma diminuição estatisticamente significativa do acúmulo de leucócitos na neoíntima em cinco e 28 dias (controle: 42,3±12,9 por cento versus anti-M2: 24,6±10,8 por cento, p=0,047 e controle: 7,9±3,0 por cento versus anti-M2: 3,3±1,3 por cento, p=0,012; respectivamente). A proliferação celular na camada média do vaso em cinco dias pós-lesão foi reduzida com o bloqueio da interação Mac-1-GPIba (controle: 5,0±2,9 por cento do total de células versus anti-M2: 1,8±0,5 por cento; p=0,043), assim como houve diminuição significativa da proliferação celular na camada íntima do vaso em 28 dias (controle: 3,8±1,7 por cento versus anti-M2: 2,0±1,2 por cento; p=0,047). O bloqueio da interação Mac-1-GPIba também determinou uma redução estatisticamente significativa do espessamento intimal em 28 dias pós-lesão (controle: 10.395±3.549 µm² versus anti-M2: 4.561±4.915 ...

OBJECTIVE: To assess the importance of the interaction between leukocyte integrin Mac-1 (a Mb 2) and platelet glycoprotein (GP) Ib-a for leukocyte recruitment after vascular injury and the effect of the neutralization of the Mac-1-GPIba interaction on cell proliferation and the neointimal hyperplasia triggered by the vascular injury. METHODS: A peptide called M2 or anti-M2 antibody was developed to block the Mac-1-GPIba interaction. This peptide was injected and compared to a control-peptide in C57B1/6J mice submitted to vascular injury of the femoral artery with a guide wire. One, five or 28 days after the vascular injury, the femoral arteries were removed for morphometric and immunohistochemical analyses. RESULTS: The blocking of the Mac-1-GPIba interaction promoted a statistically significant reduction in the number of leukocytes in the neointimal layer on the first day after the vascular injury (control: 7.9±5.0 percent of the cell total versus anti-M2: 2.0±1.6 percent, p=0.021), as well as determined a statistically significant decrease in leukocyte accumulation in the neointimal layer on days 5 and 28 (control: 42.3±12.9 percent versus anti-M2: 24.6±10.8 percent, p=0.047 and control: 7.9±3.0 percent versus anti-M2: 3.3±1.3 percent, p=0.012; respectively). Cell proliferation in the neointimal layer of the vessel five days post-injury was reduced with the blocking of the Mac-1-GPIba interaction (control: 5.0±2.9 percent of the cell total versus anti-M2: 1.8±0.5 percent; p=0.043), along with a significant decrease in cell proliferation in the vessel neointimal layer 28 days post-injury (control: 3.8±1.7 percent versus anti-M2: 2.0±1.2 percent; p=0.047). The blocking of the Mac-1-GPIba interaction also determined a statistically significant decrease of the intimal thickening 28 days post-injury (control: 10,395±3,549 µm² versus anti-M2: 4,561±4,915 µm²; ...

Estudo comparativo entre os efeitos terapêuticos da revascularizacão cirúrgica do miocárdio e angioplastia coronária em situacões isquêmicas equivalentes: análise através da cintilografia do miocárdio com 99mTc-Sestamibi / Comparative study between the therapeutic effects of surgical myocardial revascularization and coronary angioplasty in equivalent ischemic situations: analysis through myocardial scintigraphy with 99mTc-Sestamibi

OBJETIVO: Avaliar a carga isquêmica do miocárdio prévia e ulterior à revascularizacão do miocárdio. MÉTODOS: Foram avaliados 96 pacientes randomizados, portadores de doenca arterial coronariana multivascular, angina estável, funcão do ventrículo esquerdo preservada e isquemia miocárdica esforco-induzida tratados com revascularizacão cirúrgica (RCM) ou angioplastia coronariana (ATC). Cintilografia do miocárdio com 99mTc-Sestamibi foi realizada antes e 6 meses após a revascularizacão do miocárdio. RESULTADOS: A RCM determinou índice significantemente maior de revascularizacão completa (p=0,001), aumento no número de testes ergométricos máximos (p=0,001) e reducão no número de testes ergométricos positivos com angina de esforco (p=0,018). Ambos os procedimentos ofereceram melhora importante na classe funcional da angina (p=0,001), aumento no valor médio do duplo produto de pico (p=0,009), e do tempo de tolerância ao esforco (p<0,001), além de reducão no valor médio da somatória do escore do esforco (p<0,001) e da diferenca da somatória dos escores (p<0,001) nos dois grupos. CONCLUSAO: ATC e RCM não diferiram significantemente quanto à reducão da carga isquêmica do miocárdio 6 meses após o procedimento. A revascularizacão do miocárdio foi mais completa com a RCM do que com a ATC, mas não representou fator significante para reducão da carga isquêmica do miocárdio.

Marcadores inflamatórios intracoronarianos após intervenções coronarianas percutâneas / Intracoronary inflammatory markers after percutaneous coronary interventions

OBJETIVO: Analisar a liberação intracoronariana de marcadores inflamatórios (MI) após intervenções coronarianas percutâneas (ICP) e comparar suas concentrações com relação ao tipo de ICP utilizada (rotablator vs angioplastia por balão). MÉTODOS: Foram randomizados 22 pacientes com média de idade de 60±11,9 anos, 12 do sexo masculino, portadores de síndromes coronarianas estáveis, submetidos ao tratamento eletivo de uma única lesão coronariana utilizando rotablator (N=11) ou pré-dilatação por balão (N=11) para implante de stents. As amostras foram colhidas na raiz da aorta e no seio coronariano, imediatamente antes e 15 minutos após as intervenções. Todas as dosagens foram feitas antes do implante do stent, sendo analisadas as citocinas TNF-a, IL-6 e IL-1 e as moléculas de adesão solúveis ICAM-1, E-selectina e P-selectina, utilizando o método ELISA. RESULTADOS: As concentrações de TNF-a e IL-6 aumentaram após as ICP, passando respectivamente de 9,5±1,5 pg/ml para 9,9±1,8 pg/ml (p=0,017) e de 6,0±2,4 pg/ml para 6,9±3,0 pg/ml (p<0,001). Não houve mudança significativa na expressão de IL-1, ICAM-1 e P-selectina, observando-se diminuição nas concentrações de E-selectina após os procedimentos (52,0±17,5 ng/ml para 49,3±18,7 ng/ml; p=0,009). Não houve diferença significativa entre as concentrações dos MI após as ICP, com relação ao tipo de procedimento utilizado. CONCLUSAO: No período precoce, pós-intervenções coronarianas percutâneas, observou-se aumento das concentrações intracoronárias de TNF-a e IL-6 e ausência de diferença significativa entre as concentrações dos marcadores inflamatórios liberados na circulação coronariana por rotablator e pela angioplastia com balão.

Efeito do enalaprilato na cardiotoxidade induzida pela doxorubicina / Effect of enalaprilat on cardiotoxicity induced by doxorubicin

PURPOSE: To evaluate whether the enalaprilat, an angiotensin converting enzyme inhibitor, was able to prevent the myocardial damage induced by doxorubicin (DOX). METHODS: Four groups composed of 10 Wistar rats each were followed for seven weeks: control (CONT); treated with enalaprilat (ENA, 1mg/kg/d/sc) treated with doxorubicin (DOX, 25 mg/kg/d/sc), and treated with doxorubicin plus enalaprilat (DOX+ENA). In eight animals of each group, the left ventricle (LV) was prepared for morphometric study and stained with HE and picro-sírius for identifying muscle fibers and collagen. In each group three fragments of the LV were examined with electronic microscopy (EM). For statistical analysis: the one-way analysis of variance was performed and was followed by multiple comparisons test when the difference between groups were detected p values < or = 0.05 were considered significant. RESULTS: Light microscopy-it was not found any significant difference among the groups for muscle fibers patterns and proportion of collagen fibers of left ventricle. Electronic microscopy-the cristolysis index (proportion between normal and damage mitochondria) demonstrated significant difference between DOX and DOX+ENA groups (30.1 vs 11.6, p < or = 0.01). CONCLUSION: ENA prevented cardiotoxic alterations induced by DOX minimizing the aggression to the mitochondria and these findings, if confirmed in anima nobilis, may open a new clinical use for this type of drug.

Cirurgia cardíaca com circulação extracorpórea em gestantes. Análise da evolução materno-fetal / Cardiopulmonary Bypass Surgery in Pregnants. Analysis of Maternal and Fetal Outcome

PURPOSE--To analyze maternal and fetal outcome in pregnant undergone to cardiac surgery. METHODS--We studied the evolution of 30 pregnant women submitted to cardiac surgery at the Hospital São Paulo, between Jan/81 and Dec/92 and, further, attended at this Hospital till the parturition. The following variables were analyzed: cardiopulmonary bypass, time of the procedure and time of the anoxia, patient temperature, surgical complications, and neonatal, maternal and fetal outcomes. RESULTS--All patients had rheumatic heart disease and, in 17, mitral stenosis was the main anatomic abnormality. Mitral commissurotomy was performed in 24 patients, double comissurotomy (mitral and aortic) in 1 patient and valve replacement was performed in 5. Cardiopulmonary bypass was utilized in all procedure; occurrence of surgical complications (p < 0.001) and the prolonged surgical time (p = 0.009) were related to the fetal mortality. There was 4 (13.3) maternal deaths and 10 (33.3) fetal deaths related to the surgery. CONCLUSION--The indication of cardiac surgery in pregnant women is heart failure, refractory to conventional therapy; cardiopulmonary bypass is associated with high fetal mortality.

'Efeitos hemodinâmicos agudos da ibopamina, captopril e placebo em pacientes com insuficiência cardíaca grave / Acute Hemodynamic Effects of Ibopamine, Captopril and Placebo in Patients with Severe Congestive Heart Failure

PURPOSE--To evaluate the acute hemodynamic effects of ibopamine (IBO), captopril (CAP) and placebo (PLA) in patients with severe congestive heart failure at rest. METHODS--Twelve male patients in sinus rhythm with dilated cardiomyopathy and NYHA class IV were studied with Swan-Ganz hemodynamics. Drugs were given in a blinded fashion. Rest, 30 min and every hour for 5 h measurements were made after oral ingestion of 100 mg IBO, 25 mg CAP or PLA. Prior to the study, patients were on diuretics as the only medication for at least 48 h. Comparisons were made with analysis of variance of repeated measurements and Duncan's multiple comparisons procedure. RESULTS--Significant increase in cardiac index and stroke volume index and reduction in systemic vascular resistance were observed with IBO and CAP for 2 h after ingestion. IBO however increased right and left filling pressures in the first hour after its administration. Ventricular tachycardia occurred in 2 patients 1 h after IBO administration. CONCLUSION--Both IBO and CAP improved hemodynamic parameters in the first two hours after oral ingestion in patients with dilated cardiomyopathy in class IV.

Análise das características do ritmo juncional em pacientes com taquicardia por reentrada nodal submetidos a ablação da via lenta por radiofreqüência / Characteristics of Junctional Rhythm During Radiofrequency Catheter Ablation of Slow Pathway in Atrioventricular Nodal Reentrant Tachycardia

PURPOSE--To study the quantitative and qualitative aspects of junctional rhythm (JR) during radiofrequency (RF) catheter ablation of slow pathway in atrioventricular nodal reentrant tachycardia. METHODS--Twenty five patients, 5 males, ages ranging from 15 to 76 years, with recurrent atrioventricular nodal reentrant tachycardia, underwent to RF catheter ablation of slow pathway. During RF applications (40V, duration 60s) electrocardiographic was continuously recorded. The recordings were posteriorly used to study the presence and characteristics of JR (number of episodes, frequency and time of onset) at the effective and ineffective RF sessions. All variables were expressed as median and mean +/- SD. Univariate analysis of the effects of each variable on success or failure of ablation were performed using x2 test. A p value < 0.05 was considered significant. RESULTS--One hundred forty nine RF sessions were performed, 25 effective and 124 ineffective (mean per patient 6, range 1 to 22). JR was present in 18 of 25 effective and 44 of 124 ineffective sessions (p < 0.05). Mean time of appearance was 12s, occurring later this time in 9 of 18 effective and in 10 of 44 ineffective sessions (p < 0.05). Mean number of episodes was 3, occurring higher number in 7 of 18 effective and in 4 of 44 ineffective sessions (p < 0.05). Median of frequency of JR was 100bpm; 11 of 18 effective and 15 of 44 ineffective sessions presented higher frequencies (p < 0.05). CONCLUSION--JR during slow pathway ablation is a sensitive marker of ablation success. JR predictor of success has higher number of episodes, higher frequency and later time of appearance than that one of ineffective sessions.

Objetivo - Estudar quantitativa e qualitativamente as características do ritmo juncional (RJ) ocorrido durante o procedimento de ablação por cateter da via lenta, em pacientes com taquicardia por reentrada nodal. Métodos - Vinte e cinco pacientes (5 homens, 15 a 76 anos) foram submetidos a ablação por cateter da via lenta, utilizando radiofreqüência (RF). Durante as sessões de RF de 40V, com 1min de duração, foi realizado o registro eletrocardiográfico contínuo, na velocidade de 25mm/s. Os registros serviram, posteriormente, para análise da presença e das características do RJ (número de episódios, freqüência e tempo de aparecimento após o início da RF), nas sessões eficazes e ineficazes. As variáveis estudadas foram expressas em mediana, média e desvio-padrão. A análise univariada do efeito das mesmas no sucesso da ablação foi realizada, utilizando-se o teste do qui-quadrado. Valor de p<0,05 foi considerado significante. Resultados - Foram realizadas 149 sessões de RF (média de 6/paciente, variando de 1 a 22), sendo 25 eficazes e 124 ineficazes. O RJ esteve presente em 18 de 25 sessões eficazes e em 44 de 124 ineficazes (p<0,05). A média do tempo de aparecimento do RJ após o início da RF foi de 12s, aparecendo em tempo superior à média em 9 de 18 sessões eficazes e em 10 de 44 ineficazes (p<0,05). A média do número de episódios de RJ foi 3, sendo maior que a média em 7 de 18 sessões eficazes e em 4 de 44 ineficazes (p<0,05). A mediana da freqüência do RJ foi de 100bpm, sendo maior que esse valor em 11 de 18 sessões eficazes e em 15 de 44 ineficazes (p<0,05). Conclusão - O RJ durante ablação com RF é um marcador sensível do sucesso do procedimento. O RJ preditor de sucesso apresenta número maior de episódios, freqüência cardíaca mais elevada e aparece mais tardiamente durante o pulso de RF, quando comparado ao que resulta ineficaz

Ablação por cateter em pacientes com arritmias cardíacas refratárias utilizando técnicas de radiofrequência / Catheter ablation of refractory cardiac arrhythmias by radiofrequency current

Objetivo: Descrever a experiência inicial do Setor Eletrofisiologia Clínica da Escola Paulista de Medicina com as técnicas de ablaçäo por radiofreqüência. Métodos - Vinte pacientes com arritmias refratárias ao tratamento clínico foram submetidos a estudo eletrofisiológico para diagnóstico e ablaçäo por radiofreqüência dos circuitos de suas arritmias. Dez pacientes eram homens e 10 mulheres com idades variando de 13 a 76 anos (média de 42,4 anos). Dezenove pacientes apresentavam taquiarritmias supraventriculares: 1 taquicardia atrial e 1 fibrilaçäo atrial com resposta ventricular rápida, 5 pacientes com taquicardia reentrante nodal e 12 pacientes com taquicardia reentrante atrioventricular. Um pacientes apresentava taquicardia ventricular de via de saída de ventrículo direito. Resultados - O tempo médio do procedimento foi de 4,17 horas e o número de aplicaçöes variou de 1 a 10 (média de 3,4 aplicaçöes), 30 - 40 V cada. Obteve-se sucesso em 18/20 (90%) dos pacientes, sendo que em 15/18 (83%) dos pacientes tratados com sucesso, o procedimento diagnóstico e terapêutico foi feito só exame. Um paciente apresentou oclusäo arterial aguda relacionada ao procedimento, necessitando de trombectomia por cateter de Fogarty. Durante um seguimento médio de 4 meses nenhum paciente apresentou recorrência de taquicardia. Conclusäo - Os resultados da experiência inicial das técnicas de ablaçäo por radiofreqüencia em nosso meio sugerem que esse proceimento possa beneficiar um grande número de pacientes com taquiarritmias

Purpose - evaluate the efficacy of radiofrequency catheter ablation in patients with refractory cardiac arrhythmias. Methods - Twenty patients with refractory cardinc arrhythmias were undertaken to electrophysiologic studies for diagnosis and radiofrequency catheter ablation of their reentrant arrhythmias. Ten patients were men and 10 women with ages varyingfrom 13 to 76 years (mean = 42,4 years).Nineteen patients had supraventricular tachyarrhythmias: One patient had atrial tachycardia and 1 atrial fibrillation with rapid ventricular rate, 5 patients had reentrant nodal tachycardia, 12 patients had reentrant atrioventricular tachycardia and 1 patient had right ventricular outflow tract tachycardia. Results - the mean time of the procedure was 4,1 hours. The radiofrequency current energy applied was 40-50 V for 30-40 seconds. Ablation was successful in 18/20 (90%) patients; in 15/18 (83%) of sucessfully treated patients the same study was done for diagnosis and radiofrequency ablation. One patient had femoral arterial occlusion and was treated with no significant sequelae. During a mean follow-up of 4 months no preexcitacion or reentrant tachycardia occurred. Conclusions - the results of our experience with radiofrequency catheter ablation of cardiac arrhythmias suggest that this technique can benefit an important number of patients with cardiac arrhythmias

Ablaçäo por cateter de taquicardia de via de saída de ventrículo direito utilizando radiofrequência como fonte de energia / Catheter ablation of tachycardia of the outlet right ventricle using radiofrequency as power source

Two female patients, 54 and 38 years-old with refractory ventricular tachycardia were undertaken to electrophysiologic study for diagnosis and radiofrequency ablation of their arrhythmias. The tachycardias were only inducible with intravenous isoproterenol infusion. The site of the origin of ventricular tachycardia was localized in the right ventricular outflow tract in both cases. Radiofrequency current was delivered at 40V (40-60s) in each patient and was followed by complete abolition of ventricular arrhythmias

Estudo comparativo do ecocardiograma dopller transtorácico, tomografia computadorizada e aortografia no diagnóstico de dissecçäo da aorta torácica / Comparative Evaluation of Transthoracic Doppler Echocardiogram, Computed Tomography and Aortography in the Diagnosis of Thoracic Aortic Dissection.

PURPOSE--Comparative and prospective evaluation of three methods (transthoracic echo-Doppler (TTE), computerized tomography (CT) and aortography (AORT) utilized for aortic dissection diagnosis. METHODS--The 39 patients with confirmed aortic dissection (surgery or autopsy) underwent, within a few hours of each other, all three methods scrutinized. There were 19 cases of type A and 20 of type B dissection. RESULTS--In type A dissection the methods were equivalent (TTE = 73.7//, CT = 84.2//, AORT = 73.7//p = NS) but for type B, TTE was significantly inferior to the other two methods (TTE = 60//, TC 90//, AORT = 80//, p < 0.05 for TTE, for TC and AORT p = NS). In three occasions, even though all three methods were performed, the diagnosis was not obtained. CONCLUSION--The methods which were evaluated make the diagnosis in the majority of cases. In type A all methods are similar, however, in type B, TC and AORT are superior to TTE. Even performing all three methods in each patient, in three instances the diagnosis was not made

Ablação por cateter de foco de taquicardia atrial ectópica incessante utilizando radiofrequência: reversäo de taquicardiomiopatia / Catheter ablation of ectopic incessant atrial tachycardia using radiofrequency: reversion of tachycardiomyopathy

A 8-year-old female patient with refractory incessant atrial tachycardia, very symptomatic and with left ventricular ejection fraction of 0.25. Electrophysiological study and endocardial mapping localized the site of the origin of atrial tachycardia in the superior right atrium. In this site 2 applications of radiofrequency current (25V, 20 and 50 seconds) resulted in termination of the atrial tachycardia. She was discharged off antiarrhythmic drugs and after 2 months ejection fraction was 0.52. She was completely asymptomatic 6 months after ablation procedure

Paciente de 8 anos com história de taquicardia atrial ectópica incessante e refratária a drogas antiarrítmicas, muito sintomática e tendo grande comprometimento da função ventricular, com fração de ejeção de 0,25. A paciente foi submetida a estudo eletrofisiológico e ao mapeamento endocárdico que localizou o foco da taquicardia na regino superior do átrio direito, observando-se precocidade de 40ms do eletrograma nesse local em relação à onda P do eletrocardiograma de superfície. Nesta região foram feitas 2 aplicações de radiofreqüência de 25V com 20 e 50s de duração, com desaparecimento da taquicardia. A paciente evoluiu sem arritmia e após 2 meses a fração de ejeção era de 0,52. Atualmente, encontra-se assintomática após 6 meses de acompanhamento ambulatorial

Avaliaçäo da eficácia e tolerabilidade do Bezafibrato Retard no tratamento das hiperlipidemias primárias / Evaluation of efficacy and tolerability of bezafibrate retard in the treatment of primary hyperlipidemia

Num estudo aberto, näo comparativo, foram avaliados 20 pacientes portadores de hiperproteinemia primária, com níveis de colesterol plasmático acima de 200mg/dl e/ou triglicérides acima de 250 mg/dl, após, pelo menos, 30 dias de orientaçäo dietética. Os pacientes foram tratados com bezafibrato retard, na posologia de um comprimido de 400 mg ao dia, durante três meses. Ao término do tratamento, houve uma reduçäo significativa dos níveis séricos de colesterol total (-14,6%), triglicérides (-39,7%), bem como aumento significativo dos níveis de HDL-colesterol (+ 19,6%). As provas de funçäo hepática e renal e o hemograma dos 20 pacientes avaliados permaneceram inalterados durante o transcorrer do estudo